W.G. Shaheen & Associates Dba Whitney & CO Abbott Laboratories Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$856 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $19,799 - $22,429	-302 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $12,162 - $14,672	-200 Reduced 39.84%	302 $22,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $5,757 - $6,354	-100 Reduced 16.61%	502 $31,000
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $33,874 - $38,299	602 New	602 $36,000

Others Institutions Holding ABT

# of Institutions

3,173

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

Vanguard Group Inc Valley Forge, PA

166M
Shares

$19.6 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

74.4M
Shares

$8.75 Billion
0.34% of portfolio
Capital International Investors Los Angeles, CA

71.8M
Shares

$8.45 Billion
1.57% of portfolio
Capital Research Global Investors Los Angeles, CA

57.2M
Shares

$6.73 Billion
1.34% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account